Fluorescent Lactic Acid Bacteria and Bifidobacteria as Vehicles of DNA Microbial Biosensors
Management and quantification of effector molecules corresponding to heavy metals, toxins or different goal molecules is of nice biotechnological, social and financial curiosity. Microorganisms have regulatory proteins that acknowledge and modify the gene expression within the presence or absence of those compounds (effector molecules) via binding to gene sequences. The affiliation of those recognizing gene sequences to reporter genes will permit the detection of effector molecules of curiosity with excessive sensitivity.
As soon as investigators have these two elements-recognizing gene sequences and reporter genes that emit signals-we want an appropriate automobile to introduce each components. Right here, we propose lactic acid micro organism (LAB) and bifidobacteria as promising service microorganisms for these molecular biosensors. Using fluorescent proteins in addition to food-grade vectors and clustered repeatedly interspaced brief palindromic repeats (CRISPR) are indispensable instruments for introducing biosensors into these microorganisms. Using these LAB and bifidobacteria can be of particular curiosity for learning the intestinal setting or different advanced ecosystems.
The good number of species tailored to many environments, in addition to the opportunity of making use of a number of protocols for his or her transformation with recognizing gene sequences and reporter genes are appreciable benefits. Lastly, an effort should be made to search out recognizable gene sequences.

DNAAF5 Polyclonal Antibody |
||
A58814-050 | 50 ul | EUR 302.5 |
DNAAF5 Polyclonal Antibody |
||
A58814-100 | 100 ul | EUR 423.5 |
DNAAF5 Polyclonal Antibody |
||
A58814 |
|
|
DNAAF5 Antibody, HRP conjugated |
||
1-CSB-PA771471LB01HU |
|
|
Description: A polyclonal antibody against DNAAF5. Recognizes DNAAF5 from Human. This antibody is HRP conjugated. Tested in the following application: ELISA |
DNAAF5 Antibody, FITC conjugated |
||
1-CSB-PA771471LC01HU |
|
|
Description: A polyclonal antibody against DNAAF5. Recognizes DNAAF5 from Human. This antibody is FITC conjugated. Tested in the following application: ELISA |
DNAAF5 Antibody, Biotin conjugated |
||
1-CSB-PA771471LD01HU |
|
|
Description: A polyclonal antibody against DNAAF5. Recognizes DNAAF5 from Human. This antibody is Biotin conjugated. Tested in the following application: ELISA |
DNAAF5 Polyclonal Antibody, Biotin Conjugated |
||
A58815-050 | 50 ul | EUR 302.5 |
DNAAF5 Polyclonal Antibody, Biotin Conjugated |
||
A58815-100 | 100 ul | EUR 423.5 |
DNAAF5 Polyclonal Antibody, FITC Conjugated |
||
A58816-050 | 50 ul | EUR 302.5 |
DNAAF5 Polyclonal Antibody, FITC Conjugated |
||
A58816-100 | 100 ul | EUR 423.5 |
DNAAF5 Polyclonal Antibody, HRP Conjugated |
||
A58817-050 | 50 ul | EUR 302.5 |
DNAAF5 Polyclonal Antibody, HRP Conjugated |
||
A58817-100 | 100 ul | EUR 423.5 |
DNAAF5 Polyclonal Antibody, Biotin Conjugated |
||
A58815 |
|
|
DNAAF5 Polyclonal Antibody, FITC Conjugated |
||
A58816 |
|
|
DNAAF5 Polyclonal Antibody, HRP Conjugated |
||
A58817 |
|
|
Human Dynein Assembly Factor 5, Axonemal / HEATR2 (DNAAF5) ELISA Kit |
||
abx387761-96tests | 96 tests | EUR 1093.2 |
Positive control tissue section for each individua |
||
Control-Slides-for-each-antibody | Set of 25 | EUR 355 |
Description: Positive control tissue section for each individual antibody; Based on availability; INQUIRE |
CD11b Antibody Antibody |
||
ABD2911 | 100 ug | EUR 525.6 |
ASAP1 antibody Antibody |
||
DF8746 | 200ul | EUR 420 |
anti- Antibody^Polyclonal antibody control antibody |
||
LSMab09882 | 100 ug | EUR 525.6 |
ARHGDIA Antibody / RHOGDI Antibody |
||
F54788-0.08ML | 0.08 ml | EUR 165 |
ARHGDIA Antibody / RHOGDI Antibody |
||
F54788-0.4ML | 0.4 ml | EUR 379 |
Antibody |
||
A1360-500 | each | Ask for price |
Anti-Glycolipid Antibody (AGA) Antibody |
||
20-abx004855 |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
||
20-abx008109 |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
||
20-abx123734 |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
||
20-abx014333 |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
||
abx033330-400ul | 400 ul | EUR 627.6 |
Ly1 Antibody Reactive (LYAR) Antibody |
||
abx033330-80l | 80 µl | EUR 343.2 |
Anti-Glycolipid Antibody (AGA) Antibody |
||
abx036399-100ug | 100 ug | EUR 469.2 |
Anti-Glycoprotein Antibody (GP) Antibody |
||
20-abx319900 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
||
20-abx319901 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
||
20-abx319905 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody |
||
20-abx319913 |
|
|
Anti-Glycolipid Antibody (AGA) Antibody |
||
abx230204-100ug | 100 ug | EUR 577.2 |
Ly1 Antibody Reactive (LYAR) Antibody |
||
20-abx324434 |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
||
20-abx311665 |
|
|
Ly1 Antibody Reactive (LYAR) Antibody |
||
abx234901-100ug | 100 ug | EUR 661.2 |
Anti-Anti-SEPT6 antibody antibody |
||
STJ11100949 | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis. One version of pediatric acute myeloid leukemia is the result of a reciprocal translocation between chromosomes 11 and X, with the breakpoint associated with the genes encoding the mixed-lineage leukemia and septin 2 proteins. This gene encodes four transcript variants encoding three distinct isoforms. An additional transcript variant has been identified, but its biological validity has not been determined. |
Anti-Anti-SEPT9 Antibody antibody |
||
STJ111369 | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family involved in cytokinesis and cell cycle control. This gene is a candidate for the ovarian tumor suppressor gene. Mutations in this gene cause hereditary neuralgic amyotrophy, also known as neuritis with brachial predilection. A chromosomal translocation involving this gene on chromosome 17 and the MLL gene on chromosome 11 results in acute myelomonocytic leukemia. Multiple alternatively spliced transcript variants encoding different isoforms have been described. |
Anti-Anti-SEPT11 Antibody antibody |
||
STJ111530 | 100 µl | EUR 332.4 |
Anti-Anti-SEPT4 Antibody antibody |
||
STJ112276 | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is highly expressed in brain and heart. Alternatively spliced transcript variants encoding different isoforms have been described for this gene. One of the isoforms (known as ARTS) is distinct; it is localized to the mitochondria, and has a role in apoptosis and cancer. |
Anti-Anti-MARCH9 Antibody antibody |
||
STJ112609 | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
||
STJ113941 | 100 µl | EUR 332.4 |
Anti-Anti-SEPT11 Antibody antibody |
||
STJ114081 | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
||
STJ114819 | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-MARCH8 Antibody antibody |
||
STJ114828 | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
||
STJ116214 | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT8 Antibody antibody |
||
STJ117206 | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT12 Antibody antibody |
||
STJ117759 | 100 µl | EUR 332.4 |
Description: This gene encodes a guanine-nucleotide binding protein and member of the septin family of cytoskeletal GTPases. Septins play important roles in cytokinesis, exocytosis, embryonic development, and membrane dynamics. Multiple transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-MARCH6 Antibody antibody |
||
STJ118549 | 100 µl | EUR 332.4 |
Anti-Anti-MARCH6 Antibody antibody |
||
STJ118550 | 100 µl | EUR 332.4 |
Anti-Anti-MARCH7 Antibody antibody |
||
STJ118752 | 100 µl | EUR 332.4 |
Anti-Anti-SEPT3 Antibody antibody |
||
STJ118990 | 100 µl | EUR 332.4 |
Anti-Anti-SEPT2 Antibody antibody |
||
STJ28365 | 100 µl | EUR 332.4 |
Anti-Anti-SEPT7 Antibody antibody |
||
STJ28963 | 100 µl | EUR 332.4 |
Description: This gene encodes a protein that is highly similar to the CDC10 protein of Saccharomyces cerevisiae. The protein also shares similarity with Diff 6 of Drosophila and with H5 of mouse. Each of these similar proteins, including the yeast CDC10, contains a GTP-binding motif. The yeast CDC10 protein is a structural component of the 10 nm filament which lies inside the cytoplasmic membrane and is essential for cytokinesis. This human protein functions in gliomagenesis and in the suppression of glioma cell growth, and it is required for the association of centromere-associated protein E with the kinetochore. Alternative splicing results in multiple transcript variants. Several related pseudogenes have been identified on chromosomes 5, 7, 9, 10, 11, 14, 17 and 19. |
Anti-Anti-SEPT2 Antibody antibody |
||
STJ25475 | 100 µl | EUR 332.4 |
Anti-Anti-SEPT5 Antibody antibody |
||
STJ25477 | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin gene family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. This gene is mapped to 22q11, the region frequently deleted in DiGeorge and velocardiofacial syndromes. A translocation involving the MLL gene and this gene has also been reported in patients with acute myeloid leukemia. Alternative splicing results in multiple transcript variants. The presence of a non-consensus polyA signal (AACAAT) in this gene also results in read-through transcription into the downstream neighboring gene (GP1BB; platelet glycoprotein Ib), whereby larger, non-coding transcripts are produced. |
Anti-Anti-SEPT8 Antibody antibody |
||
STJ25479 | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of nucleotide binding proteins, originally described in yeast as cell division cycle regulatory proteins. Septins are highly conserved in yeast, Drosophila, and mouse, and appear to regulate cytoskeletal organization. Disruption of septin function disturbs cytokinesis and results in large multinucleate or polyploid cells. Multiple alternatively spliced transcript variants encoding different isoforms have been found for this gene. |
Anti-Anti-SEPT1 antibody antibody |
||
STJ119580 | 100 µl | EUR 332.4 |
Description: This gene is a member of the septin family of GTPases. Members of this family are required for cytokinesis and the maintenance of cellular morphology. This gene encodes a protein that can form homo- and heterooligomeric filaments, and may contribute to the formation of neurofibrillary tangles in Alzheimer's disease. Alternatively spliced transcript variants have been found but the full-length nature of these variants has not been determined. [provided by RefSeq, Dec 2012] |
CLCN5 Antibody / CIC-5 antibody |
||
RQ6462 | 100ug | EUR 419 |
Description: The CLCN5 gene encodes the chloride channel Cl-/H+ exchanger ClC-5. This gene encodes a member of the ClC family of chloride ion channels and ion transporters. The encoded protein is primarily localized to endosomal membranes and may function to facilitate albumin uptake by the renal proximal tubule. Mutations in this gene have been found in Dent disease and renal tubular disorders complicated by nephrolithiasis. Alternatively spliced transcript variants have been found for this gene. |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
||
48169-100ul | 100ul | EUR 399.6 |
Cytokeratin 7 antibody-Cytoskeleton Marker Antibody |
||
48169-50ul | 50ul | EUR 286.8 |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
||
065-A-01mg | 0,1 mg | EUR 321 |
Description: anti-CD22 monoclonal antibody |
Anti CD22 Antibody: CD22 Monoclonal Antibody |
||
065-A-1000ug | 1000 ug | EUR 1539 |
Description: anti-CD22 monoclonal antibody |
Antibody Pair to ApoA-V antibody |
||
10R-1876 | 100 ul | EUR 781.2 |
Description: Mouse monoclonal Antibody Pair to ApoA-V antibody |
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
||
20-abx103034 |
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
||
20-abx103035 |
|
|
Ly1 Antibody Reactive Homolog (LYAR) Antibody |
||
20-abx103036 |
|
|
Hepatitis C Virus Antibody (HCV) Antibody |
||
abx023924-1mg | 1 mg | EUR 1446 |
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
||
20-abx319902 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
||
20-abx319903 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
||
20-abx319904 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
||
20-abx319906 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
||
20-abx319907 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
||
20-abx319908 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
||
20-abx319914 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
||
20-abx319915 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
||
20-abx319916 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (HRP) |
||
20-abx319929 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (FITC) |
||
20-abx319930 |
|
|
Anti-Glycoprotein Antibody (GP) Antibody (Biotin) |
||
20-abx319931 |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (HRP) |
||
20-abx311666 |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (FITC) |
||
20-abx311667 |
|
|
Ly1 Antibody Reactive (LYAR) Antibody (Biotin) |
||
20-abx311668 |
|
|
Anti-Glycoprotein 210 Antibody (gp210) Antibody |
||
abx233571-100ug | 100 ug | EUR 577.2 |
Anti Deoxyribonucleic Acid Antibody (DNA) Antibody |
||
abx411057-50ug | 50 ug | EUR 710.4 |
Monoclonal NGF/proNGF Neutralizing Antibody Antibody |
||
AMM06679G | 0.05mg | EUR 633.6 |
Description: A Monoclonal antibody against Human NGF/proNGF Neutralizing. The antibodies are raised in Mouse. This antibody is applicable in E |
Goat anti- human Antibody^Polyclonal antibody |
||
LSMab09896 | 100 ug | EUR 525.6 |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D | 0.1mg | EUR 424.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is unconjugated. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-A390 | 0.1mg | EUR 481.2 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 390. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-A488 | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 488. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-A565 | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 565. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-A594 | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 594. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-A633 | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 633. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-A655 | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 655. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-A680 | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 680. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-A700 | 0.1mg | EUR 480 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to ATTO 700. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-ALP | 0.1mg | EUR 472.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Alkaline Phosphatase. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-APC | 0.1mg | EUR 478.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to APC . |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-APCCY7 | 0.1mg | EUR 565.2 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to APC/Cy7. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-BI | 0.1mg | EUR 475.2 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Biotin. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-DY350 | 0.1mg | EUR 496.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 350. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-DY405 | 0.1mg | EUR 483.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 405. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-DY488 | 0.1mg | EUR 471.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 488. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-DY594 | 0.1mg | EUR 474 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 594. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-DY633 | 0.1mg | EUR 468 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Dylight 633. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-FITC | 0.1mg | EUR 470.4 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to FITC. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-HRP | 0.1mg | EUR 465.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to HRP. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-P594 | 0.1mg | EUR 488.4 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to PE/ATTO 594. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-PCP | 0.1mg | EUR 478.8 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to PerCP. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-RPE | 0.1mg | EUR 476.4 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to RPE . |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692D-STR | 0.1mg | EUR 477.6 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is conjugated to Streptavidin. |
Antibody for Human alpha Tubulin Antibody |
||
SPC-692S | 0.012mg | EUR 78 |
Description: A polyclonal antibody for alpha Tubulin from Human. The antibody is produced in rabbit after immunization with human synthetic peptide of Human alpha-Tubulin. The Antibody is tested and validated for WB, ICC/IF assays with the following recommended dilutions: WB (1:1000); ICC/IF (1:100). This alpha Tubulin antibody is unconjugated. |
Anti-Noelin Antibody BIOTIN Antibody BIOTIN |
||
STJ501938 | 100 µg | EUR 703.2 |
Anti-Noelin Antibody FITC Antibody FITC |
||
STJ501939 | 100 µg | EUR 703.2 |
Anti-Noelin Antibody BIOTIN Antibody BIOTIN |
||
STJ501940 | 100 µg | EUR 703.2 |
Anti-Noelin Antibody FITC Antibody FITC |
||
STJ501941 | 100 µg | EUR 703.2 |
Anti-IgG1 Negative Control Antibody antibody |
||
STJ16100881 | 1 mL | EUR 573.6 |
Lambda Light Chain Antibody / Lambda Antibody |
||
R20161-100UG | 100ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
||
R20161BTN-50UG | 50ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
||
R20161SAF-250UG | 250ug | EUR 979 |
Lambda Light Chain Antibody / Lambda Antibody |
||
R20179-100UG | 100ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
||
R20179BTN-50UG | 50ug | EUR 409 |
Lambda Light Chain Antibody / Lambda Antibody |
||
R20179SAF-250UG | 250ug | EUR 979 |
Lambda Light Chain Antibody / Lambda Antibody |
||
RQ4975 | 100ul | EUR 419 |
Lambda Light Chain Antibody / Lambda Antibody |
||
V9032-100UG | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V9032-20UG | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V9032IHC-7ML | 7 ml | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V9032SAF-100UG | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3151-100UG | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3151-20UG | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3151CF488-100T | 100 Tests | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3151IHC-7ML | 7 ml | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3151SAF-100UG | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3152-100UG | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3152-20UG | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3152SAF-100UG | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3261-100UG | 100 ug | EUR 499 |
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm. Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki] |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3261-20UG | 20 ug | EUR 219 |
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm. Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki] |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3261SAF-100UG | 100 ug | EUR 499 |
Description: Antibodies are produced by B lymphocytes, each expressing only one class of light chain. Once set, light chain class remains fixed for the life of the B lymphocyte. In a healthy individual, the total kappa to lambda ratio is roughly 3:1 in serum (measuring intact whole antibodies) or 1:1.5 if measuring free light chains, with a highly divergent ratio indicative of neoplasm. Individual B-cells in lymphoid tissue possess either kappa or lambda light chains, but never both together. Specific rearrangement of lambda light chain of immunoglobulins can lead to loss of some protein coding genes, which does not seem to be functionally relevant (while functionally relevant miR-650 can be overexpressed). Using immunohistochemistry, it is possible to determine the relative abundance of B-cells expressing kappa and lambda light chains. If the lymph node or similar tissue is reactive, or otherwise benign, it should possess a mixture of kappa positive and lambda positive cells. If, however, one type of light chain is significantly more common than the other, the cells are likely all derived from a small clonal population, which may indicate a malignant condition, such as B-cell lymphoma. [Wiki] |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3262-100UG | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3262-20UG | 20 ug | EUR 219 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V3262SAF-100UG | 100 ug | EUR 499 |
Description: This mAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V2151-100UG | 100 ug | EUR 499 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V2151-20UG | 20 ug | EUR 219 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V2151SAF-100UG | 100 ug | EUR 499 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V2153-100UG | 100 ug | EUR 499 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V2153-20UG | 20 ug | EUR 219 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V2153CF488-100T | 100 Tests | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V2153IHC-7ML | 7 ml | EUR 499 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V2153SAF-100UG | 100 ug | EUR 499 |
Description: This antibody is specific to lambda light chain of immunoglobulin and shows no cross-reaction with kappa light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. In general the ratio of Kappa to Lambda is 3:1. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V7875-100UG | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V7875-20UG | 20 ug | EUR 219 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V7875SAF-100UG | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V7878-100UG | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V7878-20UG | 20 ug | EUR 219 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V7878SAF-100UG | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V7879-100UG | 100 ug | EUR 499 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Lambda Light Chain Antibody / Lambda Antibody |
||
V7879-20UG | 20 ug | EUR 219 |
Description: This MAb is specific to lambda light chain of immunoglobulin and shows no cross-reaction with lambda light chain or any of the five heavy chains. In mammals, the two light chains in an antibody are always identical, with only one type of light chain, kappa or lambda. The ratio of Kappa to Lambda is 70:30. However, with the occurrence of multiple myeloma or other B-cell malignancies this ratio is disturbed. Antibody to the lambda light chain is reportedly useful in the identification of leukemias, plasmacytomas, and certain non-Hodgkin's lymphomas. Demonstration of clonality in lymphoid infiltrates indicates that the infiltrate is malignant. |
Irregular Homocysteine Metabolism: An Perception of Alzheimer’s Illness from DNA Methylation
Alzheimer’s illness (AD) is a persistent neurodegenerative illness within the central nervous system that has advanced pathogenesis within the aged. The present evaluation focuses on the epigenetic mechanisms of AD, in response to the newest findings. The most effective-characterized chromatin modifications in epigenetic mechanisms is DNA methylation. Extremely replicable knowledge reveals that AD incidence is usually accompanied by methylation degree adjustments of the AD-related gene.
Homocysteine (Hcy) is just not solely an intermediate product of one-carbon metabolism but in addition an vital impartial danger issue of AD; it may possibly have an effect on the cognitive perform of the mind by altering the one-carbon metabolism and interfering with the DNA methylation course of, leading to cerebrovascular illness. Usually, Hcy could also be an environmental issue that impacts AD by way of the DNA methylation pathway with a collection of adjustments in AD-related substance. This evaluation will think about the relation between DNA methylation and Hcy and take a look at to determine their rule within the pathophysiology of AD.
TET is targeted for proteasomal degradation by the PHD-pVHL pathway to reduce DNA hydroxymethylation
Hypoxia-inducible components are heterodimeric transcription components that play an important position in a cell’s capability to adapt to low oxygen. The von-Hippel Lindau tumor suppressor (pVHL), acts as a grasp regulator of HIF exercise, and its focusing on of prolyl hydroxylated HIF-α for proteasomal degradation beneath normoxia is considered a significant mechanism for pVHL tumor suppression and mobile response to oxygen.
Whether or not pVHL regulates different targets by the same mechanism is essentially unknown. Right here, we determine TET2/Three as novel targets of pVHL. pVHL induces proteasomal degradation of TET2/3, leading to decreased international 5-hydroxymethylcytosine ranges.
Conserved proline residues inside the LAP/LAP-like motifs of those two proteins are hydroxylated by the prolyl hydroxylase enzymes (PHD2/EGLN1 and PHD3/EGLN3), which is prerequisite for pVHL-mediated degradation. Utilizing zebrafish as a mannequin, we decided that international 5-hydroxymethylcytosine ranges are enhanced in vhl-null, egln1a/b-double null and egln3-null embryos.
Subsequently, we reveal a novel perform for the PHD-pVHL pathway in regulating TET protein stability and exercise. These knowledge prolong our understanding of how TET proteins are regulated and supply new perception into the mechanisms of pVHL in tumor suppression.
Level-of-care DNA testing by routinely and sequentially performing extraction, amplification and identification in a closed-type cassette
- Nucleic acid detection is vital for scientific diagnostics; nonetheless, it’s difficult to carry out genetic testing on the point-of-care because of the tedious steps concerned in DNA extraction and the chance of cross-contamination from amplicons.
- To realize a fully-automated and contamination-free nucleic acid detection, we suggest a closed-type cassette system which allows the next steps to be operated routinely and sequentially: pattern preparation based mostly on magnetic beads, goal amplification utilizing multiplex polymerase chain response, and colorimetric detection of amplicons utilizing a serial invasive response coupled with the aggregation of gold nanoparticle probes.
- The cassette was designed to be spherical and closed, and 10 targets in a pattern might be concurrently detected by the bare eye or utilizing a spectrophotometer within the system.
- As well as, a cassette-driven system was fabricated to switch reagents between wells, to regulate the temperature of every response, and to sense the color within the detection wells. The cassette system was delicate sufficient to detect 10 genotypes at 5 single nucleotide polymorphism websites associated to the anticoagulant’s utilization, through the use of a 0.5 µL blood pattern.
- The accuracy of the system was evaluated by detecting 12 entire blood samples, and the outcomes obtained have been according to these obtained utilizing pyrosequencing. The cassette is hermetic and the entire system is absolutely computerized; the one guide operation is the addition of the pattern to the cassette, performing point-of-care genetic testing in a sample-in/answer-out means.
Human DNA Ligase 4 (LIG4) ELISA Kit |
||
abx388272-96tests | 96 tests | EUR 1093.2 |
Human DNA ligase 4, LIG4 ELISA KIT |
||
ELI-47684h | 96 Tests | EUR 988.8 |
Mouse DNA ligase 4, Lig4 ELISA KIT |
||
ELI-32012m | 96 Tests | EUR 1038 |
Chicken DNA ligase 4, LIG4 ELISA KIT |
||
ELI-47798c | 96 Tests | EUR 1113.6 |
DNA Ligase 4 Phospho-Thr650 (LIG4 pT650) Antibody |
||
20-abx322874 |
|
|
DNA Ligase 4 antibody |
||
70R-50002 | 100 ul | EUR 292.8 |
Description: Purified Polyclonal DNA Ligase 4 antibody |
DNA Ligase 4 antibody |
||
70R-35788 | 100 ug | EUR 392.4 |
Description: Rabbit polyclonal DNA Ligase 4 antibody |
DNA Ligase 4 (DNL4) Antibody |
||
20-abx014021 |
|
|
DNA Ligase 4 Blocking Peptide |
||
20-abx061782 |
|
|
DNA Ligase 4 Blocking Peptide |
||
20-abx062877 |
|
|
DNA Ligase 4 (pT650) Antibody |
||
abx216563-100ug | 100 ug | EUR 526.8 |
Recombinant T4 DNA Ligase |
||
7-03622 | 20,000IU | Ask for price |
Recombinant T4 DNA Ligase |
||
7-03623 | 100,000IU | Ask for price |
Recombinant T4 DNA Ligase |
||
7-03624 | 500,000IU | Ask for price |
T4 DNA Ligase (Recombinant) |
||
abx073011-100000IU | 100.000 IU | EUR 610.8 |
T4 DNA Ligase (Recombinant) |
||
abx073011-20000IU | 20.000 IU | EUR 309.6 |
T4 DNA Ligase (Recombinant) |
||
abx073011-500000IU | 500.000 IU | EUR 1846.8 |
DNA Ligase 4 (Phospho-Thr650) Antibody |
||
12457-100ul | 100ul | EUR 302.4 |
DNA Ligase 4 (Phospho-Thr650) Antibody |
||
12457-50ul | 50ul | EUR 224.4 |
DNA Ligase 4 (Phospho- Thr650) Antibody |
||
ABF8089 | 100 ug | EUR 525.6 |
DNA Ligase I (DNA Ligase I) Antibody |
||
abx232431-100ug | 100 ug | EUR 577.2 |
Phospho-DNA Ligase 4 (Thr650) Blocking Peptide |
||
AF8089-BP | 1mg | EUR 234 |
Recombinant (E.Coli) T4 DNA Ligase |
||
RP-374 | 20 KU | EUR 196.8 |
T4 DNA ligase |
||
402-002 | 400 WEISS UNITS | EUR 75.6 |
T4 DNA ligase |
||
402-010 | 2000 WEISS UNITS | EUR 184.8 |
DNA ligase Antibody |
||
20-abx110554 |
|
|
T4 DNA Ligase |
||
abx098136-10kU | 10 kU | EUR 385.2 |
T4 DNA Ligase |
||
abx098136-20Ku | 20 Ku | EUR 477.6 |
Recombinant ATP Dependent DNA ligase I (LIG1) |
||
4-RPB269Hu01 |
|
|
Description: Recombinant Human ATP Dependent DNA ligase I expressed in: E.coli |
Recombinant ATP Dependent DNA ligase I (LIG1) |
||
4-RPB269Ra01 |
|
|
Description: Recombinant Rat ATP Dependent DNA ligase I expressed in: E.coli |
IL-4 Interleukin 4 Human Recombinant Protein, Yeast |
||
PROTP05112-4 | Regular: 10ug | EUR 380.4 |
Description: Interleukin-4 Human Recombinant produced in yeast is a single, glycosylated polypeptide chain containing 129 amino acids.;The IL-4 is purified by proprietary chromatographic techniques. |
Human DNA ligase 1 (LIG1) |
||
1-CSB-EP012930HU |
|
|
Description: Recombinant Human DNA ligase 1(LIG1) expressed in E.coli |
DNA Ligase 4 (Phospho-Thr650) Polyclonal Conjugated Antibody |
||
C12457 | 100ul | EUR 476.4 |
100 BP DNA LADDER, 500UL PER KIT |
||
M-DNA-100BP | 1/pk | EUR 87.6 |
Description: Bioscience Mol Bio; DNA Ladder |
1 KB DNA LADDER, 500UL PER KIT |
||
M-DNA-1KB | 1/pk | EUR 84 |
Description: Bioscience Mol Bio; DNA Ladder |
DNA Ligase IV recombinant monoclonal antibody |
||
A5820 | 100ul X 3 | EUR 714 |
Description: A recombinant monoclonal antibody from rabbit against human DNA Ligase IV for WB, IHC, IF,ELISA |
DNA Ligase IV Antibody |
||
DF3613 | 200ul | EUR 420 |
DNA Ligase IV Antibody |
||
DF6588 | 200ul | EUR 420 |
DNA Ligase III Antibody |
||
DF6677 | 200ul | EUR 420 |
DNA Ligase IV Antibody |
||
49667-100ul | 100ul | EUR 399.6 |
DNA Ligase IV Antibody |
||
49667-50ul | 50ul | EUR 286.8 |
DNA Ligase I Antibody |
||
49797-100ul | 100ul | EUR 399.6 |
DNA Ligase I Antibody |
||
49797-50ul | 50ul | EUR 286.8 |
DNA ligase 3 antibody |
||
70R-12710 | 100 ul | EUR 548.4 |
Description: Affinity purified Rabbit polyclonal DNA ligase 3 antibody |
DNA ligase 3 antibody |
||
70R-12712 | 100 ul | EUR 548.4 |
Description: Affinity purified Rabbit polyclonal DNA ligase 3 antibody |
T4 DNA Ligase protein |
||
30R-2898 | 250 units | EUR 268.8 |
Description: Purified recombinant Human T4 DNA Ligase protein |
DNA ligase 3 antibody |
||
22940-100ul | 100ul | EUR 468 |
DNA ligase IV Antibody |
||
35335-100ul | 100ul | EUR 468 |
DNA ligase 3 antibody |
||
22508-100ul | 100ul | EUR 468 |
DNA ligase Antibody (HRP) |
||
20-abx109115 |
|
|
DNA ligase Antibody (Biotin) |
||
20-abx106283 |
|
|
DNA ligase Antibody (FITC) |
||
20-abx107697 |
|
|
DNA Ligase 1 Antibody |
||
20-abx141113 |
|
|
DNA Ligase 3 Antibody |
||
20-abx141114 |
|
|
T4 DNA Ligase (40000U) |
||
9K-005-0002 | 40000U | EUR 351.28 |
T4 DNA Ligase (Rapid) |
||
N103-01 | 600,000 U | EUR 675.6 |
T4 DNA Ligase Plasmid |
||
PVT7008 | 2 ug | EUR 614.4 |
pUC57- T4 DNA Ligase |
||
PVT10516 | 2 ug | EUR 319.2 |
anti-DNA Ligase I |
||
YF-PA24084 | 50 ul | EUR 400.8 |
Description: Mouse polyclonal to DNA Ligase I |
anti-DNA Ligase III |
||
YF-PA24085 | 50 ul | EUR 400.8 |
Description: Mouse polyclonal to DNA Ligase III |
anti-DNA Ligase I |
||
YF-PA12953 | 50 ul | EUR 435.6 |
Description: Mouse polyclonal to DNA Ligase I |
T4 DNA Ligase Buffer |
||
9102-1 | each | EUR 105.6 |
E. coli DNA Ligase |
||
M1217-100 | each | EUR 385.2 |
Recombinant Human 4-1BB Receptor Protein |
||
PROTQ07011-4 | 20ug | EUR 380.4 |
Description: 4-1BB Receptor, a member of the TNF superfamily of receptors, is mainly expressed on the surface of a variety of T cells, but also found in B cells, monocytes, and various transformed cell lines. 4-1BB Receptor binds to 4-1BBL to provide a co-stimulatory signal for T lymphocytes. Signaling by 4-1BB Receptor has been implicated in the antigen-presentation process and generation of cytotoxic T cells. The human 4-1BB Receptor gene codes for a 255 amino acid type I transmembrane protein containing a 17 amino acid N-terminal signal sequence, a 169 amino acid extracellular domain, a 27 amino acid transmembrane domain and a 42 amino acid cytoplasmic domain. Recombinant human soluble 4-1BB Receptor is a 167 amino acid polypeptide (17.7 kDa), which contains the cysteine rich TNFR-like extracellular domain of 4-1BB Receptor. |
Recombinant Human PF-4 (CXCL4) Protein |
||
PROTP02776-4 | 20ug | EUR 380.4 |
Description: PF-4 is a CXC chemokine that is expressed in megakaryocytes and stored in the α-granules of platelets. PF-4 is chemotactic towards neutrophils and monocytes and has been shown to inhibit angiogenesis. Recombinant human PF-4 is a 7.8 kDa protein containing 70 amino acid residues, including the four highly conserved residues present in CXC chemokines. |
Recombinant DNA-directed RNA polymerase 132 kDa polypeptide(RPO132) ,partial |
||
CSB-MP851803MHV | 20μg | Ask for price |
Description: Mammalian cell |
Recombinant DNA-directed RNA polymerase 132 kDa polypeptide(RPO132) ,partial |
||
CSB-EP851803MHV | 20μg | Ask for price |
Description: E.coli |
Recombinant DNA-directed RNA polymerase 132 kDa polypeptide(RPO132) ,partial |
||
CSB-EP851803MHV-B | 20μg | Ask for price |
Description: In Vivo Biotinylation in E.coli |
Recombinant DNA-directed RNA polymerase 132 kDa polypeptide(RPO132) ,partial |
||
CSB-YP851803MHV | 20μg | Ask for price |
Description: Yeast |
Recombinant DNA-directed RNA polymerase 132 kDa polypeptide(RPO132) ,partial |
||
CSB-BP851803MHV | 20μg | Ask for price |
Description: Baculovirus |
Recombinant TMPRSS2 Protein, Partial |
||
E80017-1 | 20 ul | EUR 423.5 |
Recombinant TMPRSS2 Protein, Partial |
||
E80017-2 | 100 ul | EUR 660 |
Recombinant TMPRSS2 Protein, Partial |
||
E80017-3 | 1 ml | EUR 2321 |
Recombinant TMPRSS2 Protein, Partial |
||
E80017 |
|
|
DNA Ligase I ELISA KIT|Human |
||
EF009143 | 96 Tests | EUR 826.8 |
Feline IL-4 Recombinant Protein |
||
R00230-4 | 5ug/vial | EUR 310.8 |
Description: IL-4 has many biological roles, including the stimulation of activated B-cell and T-cell proliferation, and the differentiation of CD4+ T-cells into Th2 cells. It is a key regulator in humoral and adaptive immunity. Feline IL-4 Recombinant Protein is purified interleukin-4 produced in yeast. |
DNA Ligase I Polyclonal Antibody |
||
ABP51182-003ml | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of DNA Ligase I from Human. This DNA Ligase I antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human DNA Ligase I at AA range: 80-160 |
DNA Ligase I Polyclonal Antibody |
||
ABP51182-01ml | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of DNA Ligase I from Human. This DNA Ligase I antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human DNA Ligase I at AA range: 80-160 |
DNA Ligase I Polyclonal Antibody |
||
ABP51182-02ml | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of DNA Ligase I from Human. This DNA Ligase I antibody is for WB, IHC-P, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the N-terminal region of human DNA Ligase I at AA range: 80-160 |
DNA Ligase III Polyclonal Antibody |
||
ABP51183-003ml | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of DNA Ligase III from Human, Mouse, Rat. This DNA Ligase III antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DNA Ligase III at AA range: 110-190 |
DNA Ligase III Polyclonal Antibody |
||
ABP51183-01ml | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of DNA Ligase III from Human, Mouse, Rat. This DNA Ligase III antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DNA Ligase III at AA range: 110-190 |
DNA Ligase III Polyclonal Antibody |
||
ABP51183-02ml | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of DNA Ligase III from Human, Mouse, Rat. This DNA Ligase III antibody is for WB, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DNA Ligase III at AA range: 110-190 |
DNA Ligase IV Polyclonal Antibody |
||
ABP51184-003ml | 0.03ml | EUR 189.6 |
Description: A polyclonal antibody for detection of DNA Ligase IV from Human. This DNA Ligase IV antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DNA Ligase IV at AA range: 560-640 |
DNA Ligase IV Polyclonal Antibody |
||
ABP51184-01ml | 0.1ml | EUR 346.8 |
Description: A polyclonal antibody for detection of DNA Ligase IV from Human. This DNA Ligase IV antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DNA Ligase IV at AA range: 560-640 |
DNA Ligase IV Polyclonal Antibody |
||
ABP51184-02ml | 0.2ml | EUR 496.8 |
Description: A polyclonal antibody for detection of DNA Ligase IV from Human. This DNA Ligase IV antibody is for WB, IHC-P, IF, ELISA. It is affinity-purified from rabbit antiserum by affinity-chromatography using epitope-specific immunogenand is unconjugated. The antibody is produced in rabbit by using as an immunogen synthesized peptide derived from the Internal region of human DNA Ligase IV at AA range: 560-640 |
Desulfotalea psychrophila DNA ligase (ligA) |
||
1-CSB-EP718299DAAA |
|
|
Description: Recombinant Desulfotalea psychrophila DNA ligase(ligA),partial expressed in E.coli |
DNA Ligase IV Conjugated Antibody |
||
C49667 | 100ul | EUR 476.4 |
DNA Ligase I Conjugated Antibody |
||
C49797 | 100ul | EUR 476.4 |
Escherichia coli DNA ligase (ligA) |
||
1-CSB-EP322745ENV |
|
|
Description: Recombinant Escherichia coli DNA ligase(ligA) expressed in E.coli |
Colwellia psychrerythraea DNA ligase (ligA) |
||
1-CSB-EP669648CBAB |
|
|
Description: Recombinant Colwellia psychrerythraea DNA ligase(ligA),partial expressed in E.coli |